I.T. Murkamilov
The relationship between the concentration of fibroblast growth factor-23 and central hemodynamics in patients with chronic kidney disease
|
№1 / 2020
|
M. Krstich, A.B. Zul'karnaev.
Modern aspects of renal transplantation as a variant of renal replacement therapy
|
№5 / 2014
|
A.S. Korelina, T.V. Zhdanova, A.V. Nazarov
Factors inducing increase of QT-interval dispersion in patients on program hemodialysis or continuous ambulatory peritoneal dialysis
|
№3 / 2012
|
O.R. Pestovskaya, N.P. Potekhin, M.Yu. Chernov
Influence of hemodialysis procedure on systolo-diastolic parameters of heart in patients with chronic heart failure
|
№2 / 2012
|
P.A. Vorobyev, L.Yu. Bezmenitsina
Epidemiology and quality of life in patients with chronic renal failire and anemia, receiving programm hemodyalisis. Part 2. Quality of life and costs of erythropoietin treatment
|
№2 / 2011
|
О.V. Rtyscheva, O.F. Kalev
Structural remodeling of myocardium in patients with arterial hypertension, receiving chronic haemodyalisis
|
№2 / 2011
|
E.V. Shutov, S.V. Lashutin, I.G. Kolomiitseva, E.V. Shuvalov
Treatment of anemia with methoxypolyethyleneglycol – epoetin beta in patients on haemodyalisis
|
№2 / 2011
|
P.A. Vorobev, L.J. Bezmelnitsyna
Epidemiology and quality of life in patients with chronic renal failire and anemia, receiving programm hemodyalisis. Part 1. Epidemiology and use of erythropoietin medications
|
№1 / 2011
|
N.A. Moukhin, V.V. Fomin
HIV-associated nephropathy: diagnostic and treatment strategy
|
№4 / 2010
|
N.A. Novikova, G.E. Gendlin, G.I. Storojakov, N.A. Tomilina, A.M. Andrusev
Survival of patients with terminal renal failure, receiving continuous ambulatory peritoneal dialysis
|
№4 / 2010
|
Hasabov N.N.
Use of erythropoietin in patients with terminal renal failure, treated with chronic hemodialysis (results of multicenter observational studs)
|
№3 / 2009
|